vancomycin has been researched along with Communicable Diseases, Emerging in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (36.36) | 29.6817 |
| 2010's | 7 (63.64) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bajaksouzian, S; Biek, D; Critchley, IA; Good, CE; Jacobs, MR; Jones, RN; Sader, HS; Windau, AR | 1 |
| Buetti, N; Gardiol, C; Marschall, J; Rion, V; Senn, L; Wassilew, N; Widmer, A | 1 |
| Cabeza-Osorio, L; Hermosa, C; Sanz-Rojas, P; Serrano-Heranz, R | 1 |
| Cattoir, V; Dargère, S; Daurel, C; Fines-Guyon, M; Margat, E; Michon, J; Verdon, R | 1 |
| del Mar Gamboa-Coronado, M; López-Ureña, D; Montoya-Ramírez, M; Quesada-Gómez, C; Rodríguez, C; Rodríguez-Cavallini, E; Somogyi, T | 1 |
| Calfee, DP | 1 |
| Au, J; Bolin, C; Malani, AN; Rutland, BE; Weese, JS | 1 |
| Ballard, SA; Grabsch, EA; Grayson, ML; Howden, BP; Johnson, PD; Seemann, T; Stinear, TP; Young, HL | 1 |
| Aminaka, M; Cui, L; Hiramatsu, K; Hori, S; Ito, T; Jin, J; Kaneko, K; Katayama, Y; Kobayashi, H; Kondo, S; Kurosawa, H; Nakamura, A; Oguri, T; Okuzumi, K; Yamakawa, J | 1 |
| Hageman, JC; McDonald, LC | 1 |
| Sen, MR; Tiwari, HK | 1 |
2 review(s) available for vancomycin and Communicable Diseases, Emerging
| Article | Year |
|---|---|
Clostridium difficile: a reemerging pathogen.
Topics: Aged; Anti-Bacterial Agents; Clostridioides difficile; Colectomy; Communicable Diseases, Emerging; Cross Infection; Enterocolitis, Pseudomembranous; Humans; Incidence; Infection Control; Metronidazole; Risk Factors; Vancomycin | 2008 |
Vancomycin intermediate and resistant Staphylococcus aureus. What the nephrologist needs to know.
Topics: Adult; Aged; Anti-Bacterial Agents; Communicable Diseases, Emerging; Cross Infection; Drug Utilization; Humans; Infection Control; Methicillin Resistance; Microbial Sensitivity Tests; Middle Aged; Nephrology; Renal Dialysis; Staphylococcal Infections; Staphylococcus aureus; Treatment Outcome; United States; Vancomycin; Vancomycin Resistance | 2004 |
9 other study(ies) available for vancomycin and Communicable Diseases, Emerging
| Article | Year |
|---|---|
Activity of ceftaroline against recent emerging serotypes of Streptococcus pneumoniae in the United States.
Topics: Anti-Bacterial Agents; Ceftaroline; Cephalosporins; Communicable Diseases, Emerging; Drug Resistance, Multiple, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Pneumococcal Infections; Serotyping; Streptococcus pneumoniae; United States | 2010 |
Emergence of vancomycin-resistant enterococci in Switzerland: a nation-wide survey.
Topics: Anti-Bacterial Agents; Communicable Diseases, Emerging; Gram-Positive Bacterial Infections; Humans; Switzerland; Vancomycin; Vancomycin Resistance; Vancomycin-Resistant Enterococci | 2019 |
[Acute meningitis by Streptococcus agalactiae in a immunocompetent male].
Topics: Anti-Bacterial Agents; Cardiotonic Agents; Ceftriaxone; Combined Modality Therapy; Communicable Diseases, Emerging; Drug Therapy, Combination; Humans; Immunocompetence; Male; Meningitis, Bacterial; Middle Aged; Pharyngitis; Respiration, Artificial; Sepsis; Streptococcal Infections; Streptococcus agalactiae; Vancomycin | 2013 |
[Community-acquired methicillin-resistant Staphylococcus aureus endocarditis due to the emerging Géraldine clone: a challenging microbiological diagnosis].
Topics: Adult; Anti-Bacterial Agents; Bacterial Typing Techniques; Communicable Diseases, Emerging; Community-Acquired Infections; Endocarditis, Bacterial; Female; Gastrectomy; Genes, Bacterial; Gentamicins; Humans; Lymphoma, B-Cell, Marginal Zone; Methicillin-Resistant Staphylococcus aureus; Mitral Valve Insufficiency; Multiple Sclerosis; Neoplasms, Second Primary; Ovarian Neoplasms; Postoperative Complications; Rifampin; Staphylococcal Infections; Stomach Neoplasms; Vancomycin | 2013 |
Predominance and high antibiotic resistance of the emerging Clostridium difficile genotypes NAPCR1 and NAP9 in a Costa Rican hospital over a 2-year period without outbreaks.
Topics: Anti-Bacterial Agents; Clindamycin; Clostridioides difficile; Clostridium Infections; Communicable Diseases, Emerging; Costa Rica; Cross Infection; Diarrhea; Disease Outbreaks; Drug Resistance, Bacterial; Electrophoresis, Gel, Pulsed-Field; Enterocolitis, Pseudomembranous; Fluoroquinolones; Genes, Bacterial; Genotype; Hospitals; Humans; Microbial Sensitivity Tests; Molecular Typing; Moxifloxacin; Ribotyping; Time Factors; Vancomycin | 2016 |
Human-to-dog transmission of methicillin-resistant Staphylococcus aureus.
Topics: Aged; Animals; Anti-Bacterial Agents; Communicable Diseases, Emerging; Dog Diseases; Dogs; Female; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin; Zoonoses | 2009 |
A sustained hospital outbreak of vancomycin-resistant Enterococcus faecium bacteremia due to emergence of vanB E. faecium sequence type 203.
Topics: Anti-Bacterial Agents; Australia; Bacteremia; Bacterial Proteins; Bacterial Typing Techniques; Communicable Diseases, Emerging; Cross Infection; Disease Outbreaks; Electrophoresis, Gel, Pulsed-Field; Enterococcus faecium; Genomics; Gram-Positive Bacterial Infections; Humans; Incidence; Meropenem; Microbial Sensitivity Tests; Phylogeny; Thienamycins; Vancomycin; Vancomycin Resistance | 2010 |
Heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA) emerged before the clinical introduction of vancomycin in Japan: a retrospective study.
Topics: Anti-Bacterial Agents; Communicable Diseases, Emerging; Humans; Imipenem; Japan; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus; Vancomycin; Vancomycin Resistance | 2012 |
Emergence of vancomycin resistant Staphylococcus aureus (VRSA) from a tertiary care hospital from northern part of India.
Topics: Anti-Bacterial Agents; Communicable Diseases, Emerging; Cross Infection; Hospitals; Humans; India; Microbial Sensitivity Tests; Staphylococcal Infections; Staphylococcus aureus; Teicoplanin; Vancomycin; Vancomycin Resistance | 2006 |